RMB acted as adviser, mandated lead arranger and funder in a multi-disciplinary deal involving Mediclinic’s ZAR28-bn financial restructuring.
RMB advised Mediclinic on its R8.4-bn acquisition of a 29.9% stake in LSE listed Spire Healthcare Group plc and R10-bn rights issue.
RMB advised Mediclinic on its R32-bn reverse take-over of Abu Dhabi-based Al Noor Hospitals Group plc and primary listing on the London Stock Exchange.
The RMB Sustainable Finance and Loan Syndication teams acted as sole mandated lead arranger, debt coordinator and sustainability agent for the debt package.
Jannie van Schalkwyk, Group General Manager: Data Science and Information Management at Mediclinic International
RMB advised Mediclinic on its R3.2-bn capital raising.
